We serve Chemical Name:3’-Bromo-4’-(1-imidazolyl)acetophenone CAS:1141669-55-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3’-Bromo-4’-(1-imidazolyl)acetophenone
CAS.NO:1141669-55-7
Synonyms:1-(3-bromo-4-imidazol-1-ylphenyl)ethanone
Molecular Formula:C11H9BrN2O
Molecular Weight:265.10600
HS Code:2933290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:34.89000
Exact Mass:263.99000
LogP:2.83740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(3-bromo-4-imidazol-1-ylphenyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-bromo-4-imidazol-1-ylphenyl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-bromo-4-imidazol-1-ylphenyl)ethanone Use and application,1-(3-bromo-4-imidazol-1-ylphenyl)ethanone technical grade,usp/ep/jp grade.
Related News: Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 3’-Bromo-4’-(1-imidazolyl)acetophenone manufacturer Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 3’-Bromo-4’-(1-imidazolyl)acetophenone supplier The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. 3’-Bromo-4’-(1-imidazolyl)acetophenone vendor But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off. 3’-Bromo-4’-(1-imidazolyl)acetophenone factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.
